Create account

Coverage dated September 22, 2026 to September 24, 2026

FDA estrogen warning’s impact on menopausal UTI deaths

Headline from The Week

The black-label warning may be gone, but the stigma still endangers older women

The Week's own description from its feed. We collect headlines and these descriptions, not full articles; read the original reporting below.

Read the reports

Reports & sources

2 articles, oldest first.

  1. Money Talks News

    Exclusive: FDA Warnings Persisted as UTIs Turned Deadly in Menopause (opens Money Talks News)

    Published

    Money Talks News's feed description

    A study of 1.8 million women found sharply lower hospitalization and death rates among those prescribed vaginal estrogen for recurrent infections

  2. The Week

    FDA estrogen warning’s impact on menopausal UTI deaths (opens The Week)

    Published

    The Week's feed description

    The black-label warning may be gone, but the stigma still endangers older women

FDA estrogen warning’s impact on menopausal UTI deaths | Since Then